Ensysce
Ensysce is a California-based clinical-stage biotechnology company that researches and develops prescription drugs for patients with chronic pain.
Business Model:
Revenue: $3.8M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Ensysce Information
Geographic Data
Address: 7946 Ivanhoe Avenue
City: La Jolla
State: CA
Zip: 92037
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$15M
Raised Total:$101M
Social
Metrics
4,952,995Website Global Rank
1,625Website Monthly Traffic
Twitter Followers
Description
Ensysce is a California-based clinical-stage biotechnology company that researches and develops prescription drugs for patients with chronic pain.
Contact Phone:
+18582634196
Contact Email:
Ensysce went public on 6/30/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/30/2021
Ticker Symbol:
ENSC
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2023 | Post-IPO Equity | $3M | 9/2019 | Grant | 1 | $14.5M |
National Institute on Drug Abuse (NIDA) National Institute on Drug Abuse (NIDA) |
11/2021 | Private Placement | $15M | 6/2022 | Post-IPO Debt | $8M | 12/2022 | Post-IPO Equity | $4.1M | 6/2010 | Series A | 1 | $1.5M |
Texas Wide Open for Business Texas Wide Open for Business Texas Wide Open for Business Texas Wide Open for Business |
6/2012 | Venture Round | 1 | $1M |
Texas Wide Open for Business Texas Wide Open for Business Texas Wide Open for Business Texas Wide Open for Business |
1/2021 | Private Equity Round | 1 | $60M |
The Global Emerging Markets Group The Global Emerging Markets Group The Global Emerging Markets Group The Global Emerging Markets Group |
9/2021 | Post-IPO Debt | $15M | 9/2018 | Grant | 1 | $9.3M |
National Institute on Drug Abuse (NIDA) National Institute on Drug Abuse (NIDA) |
7/2021 | IPO | - | 2/2023 | Post-IPO Equity | $3M | 7/2021 | IPO | - |
|
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2016 | Signature Therapeutics, Inc. |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
